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Abstract: Optical coherence tomography (OCT) is a promising imaging 
technique to evaluate small airway remodeling. However, the short-term 
insertion-reinsertion reproducibility of OCT for evaluating the same 
bronchial pathway has yet to be established. We evaluated 74 OCT data sets 
from 38 current or former smokers twice within a single imaging session. 
Although the overall insertion-reinsertion airway wall thickness (WT) 
measurement coefficient of variation (CV) was moderate at 12%, much of 
the variability between repeat imaging was attributed to the observer; CV 
for repeated measurements of the same airway (intra-observer CV) was 9%. 
Therefore, reproducibility may be improved by introduction of automated 
analysis approaches suggesting that OCT has potential to be an in-vivo 
method for evaluating airway remodeling in future longitudinal and 
intervention studies. 
©2015 Optical Society of America 
OCIS codes: (170.0170) Medical optics and biotechnology; (170.4500) Optical coherence 
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1. Introduction 
The structural changes and thickening of the airway wall components that occur in individuals 
with chronic respiratory diseases – known as airway remodeling – are thought to be 
responsible for many of the adverse outcomes associated with disease. However, our 
understanding of airway wall remodeling is based on studies that directly examine lung tissue, 
typically post-mortem, or indirectly make inferences about structure by investigating the 
functional effects of airway remodeling, such as spirometry measurements of airflow 
limitation. Even though measurements of airflow limitation are valuable and are used as 
markers of airway disease [1], these tests provide only global assessments of pulmonary 
function and no structural information at all. Therefore, to understand airway remodeling 
direct measurements of the airway wall in living subjects are required. Furthermore, airway 
diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, are known to be 
highly regional affecting only certain airways in the lung, and, as such, global functional 
measurements cannot provide us with any detailed structural or regional information to better 
understand, characterize and possibly treat the specific remodeled airway walls. 
Optical coherence tomography (OCT) is a minimally invasive imaging technique that can 
provide higher resolution images of small airway wall structure [2–12] not possible with other 
pulmonary imaging approaches, including computed tomography (CT) [13] and magnetic 
resonance imaging (MRI) with inhaled contrast agents [14]. Early investigations using OCT 
demonstrated not only that airway wall measurements correlated significantly with CT and 
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spirometry [5], but OCT can identify airway wall components in vivo that until now have only 
been visualized using histology [3, 4]. 
Despite this important early work demonstrating the potential of OCT for airway imaging 
in subjects with chronic respiratory diseases, there are no reports on the reproducibility of 
OCT for repeated airway wall measurements of the same peripheral airway paths in living 
humans. In patients at risk and with COPD, the ability to visualize and quantify the structural 
changes that occur within the small airway wall may help to inform treatment strategies to 
target the underlying disease mechanisms, as well as to help monitor response to specific 
treatments. Furthermore, indentifying individuals with significant small airway remodeling 
may help stratify patients for more targeted therapies in clinical trials, to ultimately obtain 
better therapeutic outcomes. This may be of particular importance in patients with early and 
mild disease, where spirometry measurements do not reflect patient symptoms or functional 
limitation and early intervention may slow disease progression. However, to better understand 
the role of OCT for investigating how airway remodeling is modified by therapy, the 
reproducibility of OCT must be established. The objective of this study was threefold: 1) to 
determine OCT inter- and intra-observer airway wall measurement reproducibility, 2) to 
determine the OCT probe insertion-reinsertion reproducibility for identifying and evaluating 
the same airway path twice within the same imaging session, and, 3) to determine OCT 
insertion-reinsertion airway wall measurement reproducibility. Establishing the insertion-
reinsertion technique and airway wall measurement reproducibility will allow for smallest 
detectable difference estimates and sample size calculations to help guide future longitudinal 
or intervention studies. 
2. Materials and methods 
2.1 Study subjects 
Subjects participating in an ongoing National Cancer Institute sponsored chemoprevention 
trial between 40 and 80yrs were enrolled in this study. All subjects were current or former 
smokers. COPD was defined by post-bronchodilator spirometry in accordance with the Global 
initiative for chronic Obstructive Lung Disease (GOLD) criteria [1]. The study was approved 
by the University of British Columbia’s Review of Ethics Board, and written informed 
consent was obtained for all subjects (REB H10-00226 & H07-01393). 
2.2 OCT image acquisition 
OCT imaging was performed using a frequency domain swept-source OCT system (Lightlabs 
C7XR, St. Jude Medical, Inc., St. Paul, MN, USA) and a 0.9mm diameter optical catheter (C7 
Dragonfly Imaging Catheter, St. Jude Medical Inc.) enclosed in a 1.5mm diameter clear Pebax 
sheath [15]. The OCT catheter was inserted through the biopsy channel of the bronchoscope 
into a sub-segmental airway in the lower, middle or upper lobe. Once at the sub-segmental 
bronchus entrance, the probe was gently advanced until the internal diameter of the airway 
was equal to the 1.5mm outer diameter of the probe. Three-dimensional imaging of a 5cm 
airway path distal to the entrance of the sub-segmental bronchus was obtained using a 
computer controlled pull-back of the rotating probe at 1cm/sec. The catheter was removed and 
the bronchoscope was withdrawn to the trachea. The bronchoscope was then repositioned at 
the same sub-segmental bronchus entrance and the catheter was re-inserted into the same 
airway for repeat imaging. 
2.3 OCT image analysis 
To determine if the OCT probe was positioned in the exact same airway on the second 
imaging procedure, the three-dimensional airway paths were compared and a complete match 
was defined to have occurred when all branch-points were matched in both proximal and the 
peripheral sections of the airway path (Fig. 1). A partial match was defined to have occurred 
when branch-points were matched in the proximal part of the airway segment, but not the 
peripheral section (Fig. 2). 
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Each airway segment was classified according the standard bronchial numbering system 
and grouped according to lobe. Airway wall dimensions were assessed using three 
consecutive OCT frames in each airway segment. The lumen area (Ai) and outer wall area 
(Ao) were manually segmented using ImageJ software (National Institutes of Health, 
Bethesda, MD) and the mean Ai and Ao were used to calculate the mean airway wall area 
(WA = Ai-Ao). Wall thickness (WT) was also calculated by the subtraction of the average 
lumen diameter from the average outer wall diameter; average lumen diameter was calculated 
according to Eq. (1): 
 Average lumen diameter 2
Ai
π
=    (1) 
and average outer wall diameter was calculated according to according to Eq. (2): 
 Average outer wall diameter = 2
Ao
π
      (2) 
 
Fig. 1. OCT imaging of a completely matched airway. Three-dimensional optical coherence 
tomography (OCT) images of a sub-segmental airway path obtained by the first insertion (A) 
and second insertion (B) of the OCT catheter. The branch points are shown by capital and 
lower case letters respectively. The lower images are cross-sectional OCT images of each 
branch point. 
OCT airway segmentation was performed by three observers. One observer was a 
pulmonologist with experience performing the OCT procedure and quantitative analysis; the 
second observer was an expert in quantitative imaging with experience performing the 
quantitative analysis; the third observer had no previous experience with the technique, but 
was provided with brief training. Observer 3 performed three rounds of segmentation, blinded 
to all subject demographic information and imaging time-points, with a minimum of 24 hours 
between repeated segmentation rounds to minimize memory bias. 
2.4 Statistical analysis 
Statistical comparison of demographic and spirometry measurements between subjects with 
and without COPD were performed using Mann Whitney t-tests for continuous variables 
(GraphPad Software Inc, San Diego, CA, USA). A Fisher’s exact test was used for all 
statistical comparisons of categorical variables. Inter-observer, intra-observer and insertion-
reinsertion measurement reproducibility were determined using Pearson correlation 
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coefficients (r) and Bland-Altman analysis (GraphPad Software Inc). Two-way mixed-effects 
repeated measures analysis of variance was performed to determine if there were significant 
differences between measurements made by the three observers, and the insertion-reinsertion 
measurements using SAS 9.2 software (SAS Institute, Cary, NC). 
 
Fig. 2. OCT imaging of a partially matched airway. Three-dimensional optical coherence 
tomography (OCT) images of sub-segmental airway path obtained by the first insertion (A) and 
second insertion (B) of the OCT catheter. Branch points A and B are identical but the catheter 
takes a different path at branch point C and, therefore, all peripheral branch points are different 
(yellow letters). 
For the single observer that performed repeated measurements, the intra-observer and 
insertion-reinsertion measurement intraclass correlation coefficient (ICC) (MedCalc Software, 
Ostend, Belgium) and coefficient of variation (CV) were also generated. Using the insertion-
reinsertion measurement ICC as previously described [16], the smallest detectable difference 
(SDD), defined as the magnitude of change required to exceed the technique and 
measurement error for repeat imaging at two different time-points with 95% confidence (α = 
0.05, Zα = 1.96), was calculated as shown in Eq. (3): 
 Insertion Insertion Reinsertion1.96 2 1SDD SD ICC −= −  (3) 
where SDInsertion is the standard deviation of WT measurements at the first time-point and 
ICCInsertion-Reinsertion is the intraclass correlation coefficient of insertion-reinsertion WT 
measurements. 
A sample size calculation [17] was performed to help guide future controlled treatment 
studies using the variation in the insertion-reinsertion WT measurements for subjects at risk 
and with COPD. Since no interventions were performed in this study, we determined the 
number of subjects (n) that would be required in a controlled trial to detect significant 
differences (δ) for a range of effect sizes typically measured in clinical trials following an 
intervention for WT measurements between baseline and follow-up in a control group 
(subjects at risk and with COPD receiving no treatment) and a treatment group with 95% 




2( ) DiffZ Z SDn α β
δ
+
=  (4) 
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where SDDiff was the standard deviation of the difference between baseline and follow-up in 
the no treatment group; SDDiff was estimated using the standard deviation of the difference 
between the average of the three observer’s insertion-reinsertion WT measurements; δ was the 
difference between the baseline and follow-up mean change for the control and treatment 
group. All results were considered statistically significant when the probability of making a 
Type I error was less than 5% (p<0.05). 
3. Results 
The subject demographic information for 38 current or ex-smokers are shown in Table 1. 
There were no significant differences between current or ex-smokers with and without COPD 
with respect to age (p = 0.27), smoking status (p = 0.73), and pack-years (p = 0.26), however 
there were significantly fewer females with COPD (p = 0.01). 
Table 1. Subject Demographics 
Parameter ( ± SD) All 
n = 38 
Control
n = 26 
COPD
n = 12 
Significance of Difference 
(p)* 
Age, yr ( ± SD) 62 (9) 61 (8) 65 (9) 0.27
Female, n (%) 16 (42) 7 (27) 9 (75) 0.01
Current Smoker, n (%) 14 (37) 9 (35) 5 (42) 0.73
Pack-years, yr ( ± SD) 43 (17) 43 (14) 53 (22) 0.26
FEV1%pred ( ± SD) 81 (18) 85 (13) 72 (24) 0.14
FVC%pred ( ± SD) 82 (25) 80 (26) 86 (22) 0.62
FEV1/FVC, % ( ± SD) 71 (10) 76 (5) 61 (11) <0.0001
FEV1: Forced expiratory volume in one second, FVC: Forced vital capacity, Significance of difference (p<0.05) 
determined using Mann Whitney t-tests for continuous variables and Fisher’s exact test for categorical variables. 
3.1 Inter-observer measurement reproducibility 
A total of 90 OCT airway paths from all 38 subjects were acquired; 16 OCT data sets were 
excluded as a result of poor image quality due to motion artifacts and therefore a total of 74 
data sets were included in the analysis. Table 2 shows inter-observer measurement 
reproducibility of all OCT-derived airway measurements for both the proximal and peripheral 
segments of the airway path. For all airway measurements, Pearson correlation coefficients 
were greater for Observer-1 (Pulmonologist) and Observer-2’s (Expert) measurements, than 
for Observer-1 and Observer-3′s (Inexperienced Observer) measurements. Bland-Altman 
analysis also showed there was less bias between measurements obtained by Observer-1 and 
−2, than between Observer-1 and −3 for both proximal and peripheral segments, except for 
WT. Although the Bland-Altman bias was reduced for WT measurements obtained by 
Observer-1 and Observer-3 (bias = −0.09 ± 0.10mm) than for Observer-1 and Observer-2 
(bias = −0.17 ± 0.10mm), there was a clear proportional error between Observer-1 and 
Observer-3′s measurements (Fig. 3). There was also a proportional error between Observer-2 
and Observer-3′s WT measurements at both the proximal and peripheral segment of the 
airway path. 
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Table 2.  Inter-Observer Reproducibility 
  Observer 1 vs. 2 Observer 1 vs. 3 Observer 2 vs. 3 
 Correlation Bland-Altman Correlation Bland-Altman Correlation Bland-Altman 
 r p bias 95% CI r p bias 95% CI r p bias 95% CI
Proximal      




















0.78 <0.0001 1.41 
(0.59) 
0.24-2.57
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0.27-2.54








0.68 <0.0001 0.41 
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Fig. 3. Inter-Observer Reproducibility for OCT-derived WT Measurements for both Proximal 
and Peripheral Segments of the Airway Path. 
3.2 Intra-observer measurement reproducibility 
As shown in Table 3, Pearson correlation coefficients were greater for measurements obtained 
for segmentation round 2 and 3 than between the other segmentation rounds. However, the 
Bland-Altman bias was low for WT measurements between all rounds of segmentation for 
both proximal and peripheral measurements (Fig. 4). 
Table 3. Intra-Observer Reproducibility 
 Round 1 vs. 2 Round 1 vs. 3 Round 2 vs. 3 
 Correlation Bland-Altman Correlation Bland-Altman Correlation Bland-Altman 
 r p bias 95% CI r p bias 95% CI r p bias 95% CI
Proximal      
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3.3 Insertion reproducibility 
Of the 74 airway paths evaluated, 47 (64%) were defined to be completely matched at repeat 
imaging. As shown in Fig. 5, there was significantly greater insertion reproducibility in the 
right lung (for all lobes) compared to the left (right = 74% vs. left = 29%, p = 0.002), and 
there was a complete mismatch in the left upper lobe during the reinsertion imaging 
procedure. 
 
Fig. 4. Intra-Observer Reproducibility for OCT-derived WT Measurements for both Proximal 
and Peripheral Segments of the Airway Path. 
 
Fig. 5. Insertion-reinsertion Reproducibility. LLL = left lower lobe, LUL = left upper lobe, 
RLL = right lower lobe, RML = right middle lobe, RUL = right upper lobe. 
3.4 OCT insertion-reinsertion measurement comparison 
There were significant differences between all three observers for peripheral Ai (p = 0.04), 
WA (p = 0.04), WT (p = 0.02), and proximal Ao (p = 0.04), WA (p = 0.03) and WT (p = 
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0.02) (Table 4). However, there were no significant differences for any of the airway 
measurements between insertion and reinsertion (p>0.05). 
Table 4. OCT Measurements for Each Observer at Insertion and Reinsertion 
 
3.5 Insertion-reinsertion measurement reproducibility 
Table 5 shows the insertion-reinsertion measurement reproducibility for all OCT-derived 
airway measurements for both the proximal and peripheral segments of the airway path, as 
well as for those airway paths that were matched or un-matched at repeat imaging. The 
Pearson correlation coefficients and Bland-Altman bias was similar for airway measurements 
that were matched and un-matched at repeat imaging. Although the 95% confidence intervals 
were slightly greater for un-matched WT measurements, negligible Bland-Altman bias was 
shown for WT measurements regardless of whether they were matched or un-matched 
between repeat imaging or whether the airway segment was proximal or peripherally located 
(Fig. 6). 
Table 5. Insertion-reinsertion Measurement Reproducibility for both Proximal and 
Peripheral Segments of the Airway Path 
 Insertion-Reinsertion Matched Insertion-Reinsertion Unmatched 
 Correlation Bland-Altman Correlation 
 r p  r p r p 
Proximal   Proximal Proximal   
Ai (mm2) 0.81 <0.0001 Ai (mm2) 0.81 <0.000
1 
Ai (mm2) 0.81 <0.00
01 
Ao (mm2) 0.91 <0.0001 Ao (mm2) 0.91 <0.000
1 
Ao (mm2) 0.91 <0.00
01 
WA (mm2) 0.95 <0.0001 WA (mm2) 0.95 <0.000
1 
WA (mm2) 0.95 <0.00
01 
WT (mm) 0.93 <0.0001 WT (mm) 0.93 <0.000
1 
WT (mm) 0.93 <0.00
01 
Peripheral   Peripheral Peripheral   
Ai (mm2) 0.66 <0.0001 Ai (mm2) 0.66 <0.000
1 
Ai (mm2) 0.66 <0.00
01 
Ao (mm2) 0.90 <0.0001 Ao (mm2) 0.90 <0.000
1 
Ao (mm2) 0.90 <0.00
01 
WA (mm2) 0.91 <0.0001 WA (mm2) 0.91 <0.000
1 
WA (mm2) 0.91 <0.00
01 
WT (mm) 0.91 <0.0001 WT (mm) 0.91 <0.000
1 
WT (mm) 0.91 <0.00
01 
 
 Observer 1 Observer 2 Observer 3 Significance of Difference 
(p) 




Peripheral     
Ai (mm2) 1.95 (0.11) 1.94 (0.09) 1.80 (0.05) 1.80 (0.05) 1.80 (0.06) 1.80 (0.06) 0.04 0.47 
Ao (mm2) 3.00 (0.40) 3.01 (0.39) 3.25 (0.53) 3.45 (0.48) 2.55 (0.19) 2.56 (0.18) 0.14 0.24 
WA (mm2) 1.04 (0.37) 1.07 (0.37) 1.44 (0.52) 1.65 (0.48) 0.76 (0.16) 0.76 (0.16) 0.04 0.28 
WT (mm) 0.37 (0.12) 0.38 (0.12) 0.51 (0.16) 0.58 (0.14) 0.29 (0.05) 0.29 (0.06) 0.02 0.28 
Proximal     
Ai (mm2) 2.29 (0.41) 2.28 (0.50) 2.11 (0.38) 2.10 (0.43) 2.12 (0.38) 2.09 (0.39) 0.60 0.92 
Ao (mm2) 3.99 (0.90) 4.00 (0.95) 4.39 (0.91) 4.52 (0.89) 3.07 (0.53) 3.03 (0.51) 0.04 0.41 
WA (mm2) 1.69 (0.64) 1.72 (0.64) 2.28 (0.71) 2.42 (0.66) 0.95 (0.20) 0.94 (0.16) 0.03 0.22 
WT (mm) 0.54 (0.17) 0.55 (0.17) 0.72 (0.18) 0.76 (0.17) 0.33 (0.05) 0.33 (0.04) 0.02 0.28 
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Fig. 6. Insertion-reinsertion Reproducibility for OCT-derived WT Measurements for both 
Proximal and Peripheral Matched and Un-matched Segments of the Airway Path. 
Since the peripheral segments of the airway path are the likely targets for airway 
interventions, we provided a comparison between intra-observer and insertion-reinsertion WT 
measurement reproducibility calculated using the ICC and CV in Table 6. The insertion-
reinsertion measurement CV was 12% (matched CV = 11%, un-matched CV = 15%) and only 
slightly higher than the intra-observer CV of 9%. The SDD for WT measurements was 
0.08mm (matched SDD = 0.07mm, un-matched SDD = 0.09mm), and the sample sizes 
required for effect sizes of 10%/15%/20% (which corresponds to changes of magnitude 
0.04mm, 0.06mm, 0.08mm) for all airway segments evaluated were 29/13/7. 
Table 6. Comparison between Intra-Observer and Insertion-reinsertion Reproducibility 
for Peripheral WT Measurements 
Reproducibility Estimate
Intra-observer CV (%) 9
Intra-observer ICC [95% CI] 0.82 [0.75-0.88]
Insertion-reinsertion CV (%) 12
 Matched 11
 Un-matched 15
Insertion-reinsertion ICC [95% CI] 0.69 [0.55-0.79]
 Matched 0.81 [0.68-0.89]




Sample Size Estimates for Effect Size:
 10% (0.04 mm) 29
 15% (0.06 mm) 13
 20% (0.08 mm) 7
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4. Discussion 
OCT is a bronchoscopic imaging technique that may have very important advantages over 
other imaging modalities for evaluating airway remodeling over time. While CT and MRI can 
provide volumetric images of the whole lung, only OCT can access and evaluate the small 
airways – the major site of airflow limitation in COPD [18]. However, in order to confidently 
assign changes in airway wall structure measured over time to the actual disease process and 
not variations in the imaging technique or observer, the reproducibility of both the OCT 
image acquisition technique and measurement procedure must be established. 
The first step in assessing reproducibility is to evaluate inter/intra-observer measurement 
reproducibility. In the present study, we demonstrated inter/intra-observer measurement 
reproducibility was high overall, and, not surprisingly, inter-observer measurement 
reproducibility was greater for more experienced observers. Light signal intensity decreases 
as depth penetration increases in OCT images, and therefore inexperienced observers may 
have difficulty distinguishing the outer wall boundary. Importantly, this may explain the 
proportional error observed in the Bland-Altman analysis when comparing more experienced 
observer’s measurements with those of the less experienced observer. However, the finding 
that there was reduced bias between the two experienced observer’s measurements suggests 
that reproducibility improves with increased training. 
Second, the reproducibility of the technique must be established to determine whether the 
same airway segment can be evaluated at different time-points. Because the OCT probe is a 
small flexible fiberoptic probe that is passed beyond the end of the bronchoscope, it may start 
out in a specific and known proximal airway segment, but there is potential for the probe to 
end up in a different, adjacent peripheral airway if it enters a different airway at the 
bifurcation point. Our findings indicates that the reproducibility of the probe entering the 
exact same peripheral airway segment was greatest in the right lung, and this is likely because 
of the straighter pathway for the probe to follow into the right middle and lower lobe. In 
contrast, the probe must negotiate sharp turns to enter either the right or left upper lobe, and 
this curvature may explain some of the reduced, or non-existent, upper lobe insertion 
reproducibility. For future studies evaluating the small airways, targeting airways in the right 
lobe will yield greater repeat imaging insertion reproducibility compared to the left. 
Furthermore, we must acknowledge that insertion-reinsertion reproducibility could have been 
greatly improved by a number of approaches, and further investigation into methods to 
improve insertion-reinsertion reproducibility are certainly warranted. For example, advancing 
the OCT probe through a guide sheath marked at the proximal end to determine the distance 
extended from the bronchoscope may improve reproducibility. 
Third, serial imaging in the same subject may not result in identical images due to 
technical factors, such as breathing/cardiac motion artifacts, small changes in image 
orientation or mucus movement between image acquisitions, and this will impact 
measurement reproducibility. The short-term insertion-reinsertion measurement 
reproducibility in peripheral airways reported here was determined to be moderate for both 
matched (CV = 11%) and un-matched (CV = 15%) airway segments. To provide context, 
FEV1 is the primary end-point that regulatory authorities regard as an acceptable measure to 
evaluate treatment efficacy for COPD patients in clinical trials [19]. Furthermore, FEV1 is 
thought to be one of the most highly reproducible lung function parameters; the coefficients 
of variation for FEV1 have been reported to be approximately 11% in patients with 
obstructive lung disease [20]. Therefore, OCT WT measurements have comparable 
reproducibility as established pulmonary function measurements that are used in clinical 
trials. Furthermore, the short-term insertion-reinsertion measurement reproducibility in 
peripheral airways was approximately the same as intra-observer measurement reproducibility 
(CV = 9%). This important finding suggests that much of the variability between repeat 
imaging, at least in this general disease type (mild COPD), can be attributed largely to the 
observer and not to the variability introduced by reinsertion of the OCT probe. This finding 
provides strong motivation for future studies to develop and validate automated segmentation 
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approaches to eliminate intra-observer variability and allow for even smaller differences to be 
detected in serial investigations. Furthermore, the finding that there was similar insertion-
reinsertion measurement reproducibility for un-matched and matched airway segments may 
suggest that the heterogeneity of airway wall structure is relatively small within specific 
regions of the lung. Therefore, in studies evaluating disease longitudinally, complete 
matching of the OCT airway paths may not be necessary. 
Finally, using the variability in the insertion-reinsertion measurements we were able to 
provide smallest detectable difference and sample size calculations to provide guidance for 
future studies. The current American Thoracic Society (ATS) and European Respiratory 
Society (ERS) guidelines state that spirometry measurements are standards for diagnosing 
COPD and evaluating treatment efficacy [21]. However, it is well-known that spirometry has 
limited sensitivity in COPD, and, as a result, large sample sizes are required to detect 
significant disease-related changes. Imaging the lung structure directly, however, may 
improve sensitivity and therefore reduce sample sizes and length of study times by a 
significant amount. For example, Dirksen et. al. [22] demonstrated in a cohort of subjects 
with alpha-1 anti-trypsin deficiency that to detect a treatment effect using FEV1 would require 
550 subjects whereas CT measurements of lung density would require only 130 subjects. 
While CT can assess the lung parenchyma serially, as was described by Dirksen and 
colleagues, other imaging approaches, such as OCT, are required to assess the small airways. 
We did not investigate whether OCT has sufficient sensitivity to detect small changes over 
time or in response to treatment in this study, however a critical first step to achieve this is to 
evaluate the reproducibility of the technique and measurements in order to provide estimates 
of the number of subjects that would be required for controlled studies. Our estimates that less 
than 30 subjects would be required to detect significant treatment effects bodes well for the 
use of OCT imaging in serial studies. 
We acknowledge that this study was limited by several factors. First, the OCT catheter 
insertion reproducibility was assessed within the same study session instead of over two 
separate sessions. Therefore, the short-term variability that may be introduced by technical 
factors, or by short-term disease-related changes, between two imaging sessions was not 
assessed. However, it is important to first establish if the technique is reproducible at all, and 
our data suggests that it is possible to obtain reproducible measurements. Second, we only 
evaluated current or ex-smokers and airway changes may be more variable over time in 
diseases like asthma, and therefore the short-term reproducibility of OCT measurements in 
asthmatics should also be investigated. Third, several OCT images were discarded due to 
technical reasons and not included in the analysis, nor were they accounted for in our sample 
size calculations. We acknowledge that more effort should be made immediately following 
image acquisition to assess the image quality and repeat imaging if necessary. Finally, 
although the OCT airway wall thickness measurements used in this study have been recently 
validated using histology in porcine airways [15], the OCT measurements have not been 
validated using histology in human airways. We acknowledge that, in addition to evaluating 
the reproducibility of a measurement, evaluating measurement accuracy in comparison to the 
actual pathology is important and should be an aim of future research. Other investigations 
have, however, demonstrated that the airway wall features measured in vivo using OCT agree 
with histology of the corresponding airway segment in patients that had undergone lung 
resections [10]. This previous work provides strong support that measurements of airway wall 
thickness obtained using OCT reflect the actual airway pathologic changes in disease. 
OCT technology is constantly evolving. While our study provides the framework for 
evaluating OCT insertion-reinsertion technique and WT measurement reproducibility, further 
research will be required as the field matures. Specifically, for our investigation, image 
acquisition commenced after we advanced the OCT probe until it fit within the airway of 
interest. However, in future studies that involve serial assessments over longer periods of time 
it may be more appropriate to advance the probe a known distance from a specific landmark, 
for example the carina, to ensure that the same airway segment is evaluated. Therefore, when 
new image acquisition protocols are introduced, evaluating the technique and measurement 
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reproducibility will be required. Furthermore, as the OCT probe technology advances and 
smaller diameter probes are introduced that are capable of evaluating the more distal airways, 
additional reproducibility studies will also be required. Clearly, there is considerable work to 
be done in the long-term before OCT will be used in specific clinical investigations, but our 
study is the first to begin to answer these questions and provide the framework for 
understanding and evaluating the sources of variability. 
5. Summary and conclusions 
In summary, we demonstrated that insertion-reinsertion reproducibility of the OCT probe was 
greatest in the right lung than the left (74% vs. 29%). We also demonstrated that while the 
overall insertion-reinsertion airway wall thickness measurement reproducibility was moderate 
in the peripheral airways (CV = 12%), much of the variability between repeat imaging was 
attributed to the observer (intra-observer CV = 9%). We also provided smallest detectable 
difference estimates and sample size calculations to help guide future serial studies evaluating 
airway remodeling. Taken together, these findings suggest that more targeted probe insertion 
within the right lung will improve insertion-reinsertion technique reproducibility, and the 
introduction of automated measurement approaches will greatly improve insertion-reinsertion 
measurement reproducibility thereby allowing even smaller differences in airway wall 
structure to be detected over time. In conclusion, this study demonstrates that OCT has the 
potential to be used in future longitudinal studies to provide a better understanding of disease 
pathogenesis and response to treatment. 
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